VISCHER advises the investors in Sequana Medical (previously NovaShunt AG) in Zurich in a Series B financing round of CHF 23.7 million (about USD 25 million) led by BioMedInvest AG I, Entrepreneurs Fund and Capricorn Health-tech Fund. The Company?s ALFApump System is a proprietary, implantable pump system that continually removes excess abdominal fluid, known as ascites, in patients suffering from liver cirrhosis, certain cancers and congestive heart failure. VISCHER lead by Matthias Staehelin with Tanja Gustinetti advises the investors.